Clinical Trials in Chicago

Showing 11761-11780 of 20,493 trials

Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy

NCT00456833

This study aims to assess the value of combined treatment with RAD001 and erlotinib in patients with advanced Non Small Cell Lung Cancer treated only with chemotherapy as systemic therapy.

Non Small Cell Lung Cancer

Novartis Pharmaceuticals248 participantsStarted Jun 2005

Atlanta, Georgia, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +11 more locations

COMPLETEDPhase 32.2 miles

Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia

NCT00084071

The purpose of this study is to determine whether tifacogin is effective and safe in the treatment of patients with severe community-acquired pneumonia.

Pneumonia

Novartis Pharmaceuticals2,136 participantsStarted May 2004

Mobile, Alabama, United States • Loma Linda, California, United States • Los Angeles, California, United States +147 more locations

Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy

Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia

Find Trials by Condition in Chicago

Pharmacokinetics and Safety of rFVIIIFc Manufactured at 15,000 L (15K) Scale

Phase I/IIa Study of FIXFc in Hemophilia B Patients

Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)

Dose Finding Study for QAW039 in Asthma

Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B

Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes

A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors

Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF（Tumor Necrosis Factor）Therapy

Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Helicobacter Pylori Genome Project (HpGP)

Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors

Efficacy, Safety, and Pharmacokinetics of QAW039

Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma.

Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients

A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer

Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients

Pharmacokinetics of rFVIIIFc at Two Vial Strengths

A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors